From: Genetic and clinical study of myeloperoxidase's association with coronary artery disease
Variables | CAD (n = 70) | Control (n = 30) | P-value |
---|---|---|---|
Age (Years) | 58.8 ± 9.9 | 51.6 ± 10.8 | 0.0036* |
Age range | 41–85 | 33–75 | – |
Renal function tests | |||
urea (mg/dL) | 36.6 ± 17.4 | 30.8 ± 10.1 | 0.1113 |
Creatinine (mg/dL) | 1.9 ± 7.9 | 0.8 ± 0.3 | 0.0062* |
Liver function tests | |||
GPT (U/L) | 12.4 ± 8 | 9.7 ± 4.8 | 0.1500 |
GOT (U/L) | 25.5 ± 22.9 | 20.4 ± 10 | 0.1823 |
Total Bilirubin (mg/dL) | 0.5 ± 0.3 | 0.4 ± 0.2 | 0.0090* |
Alp (U/L) | 78.5 ± 21.9 | 72.5 ± 24 | 0.0405* |
LDH (U/L) | 235 ± 185.3 | 198.6 ± 124.9 | 0.4205 |
Lipid profile and lipid ratios | |||
Cholesterol (mg/dL) | 154.5 ± 42.5 | 156.9 ± 37.9 | 0.8268 |
TG (mg/dL) | 172.2 ± 98.6 | 190.5 ± 81.8 | 0.2648 |
HDL (mg/dL) | 36.3 ± 7.8 | 38.1 ± 12.6 | 0.9806 |
LDL (mg/dL) | 86.5 ± 38.7 | 80.3 ± 32.3 | 0.5282 |
TG/HDL-C ratio | 5.3 ± 4.4 | 5.7 ± 3.5 | 0.3619 |
LDL-C/HDL-C ratio | 2.5 ± 1.4 | 2.2 ± 0.9 | 0.6711 |
Cardiac function tests | |||
CRP (mg/L) | 22.7 ± 65.3 | 6.5 ± 9.6 | 0.2001 |
CKmB (U/L) | 25.1 ± 41.3 | 18.7 ± 25.3 | 0.2729 |
Troponin (ng/mL) | 1.5 ± 4.7 | 0.1 ± 0.01 | 0.0042* |
Glucose (mg/dL) | 154 ± 77.6 | 110.1 ± 46.5 | 0.0042* |